Parkman Healthcare Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-719,965
| Closed | -$8.19M | – | 103 |
|
|
2024
Q3 | $8.19M | Buy |
719,965
+98,874
| +16% | +$1.13M | 1.05% | 36 |
|
|
2024
Q2 | $4.43M | Buy |
621,091
+350,955
| +130% | +$2.51M | 0.59% | 59 |
|
|
2024
Q1 | $1.81M | Buy |
+270,136
| New | +$1.81M | 0.22% | 87 |
|
|
2023
Q4 | – | Sell |
-185,613
| Closed | -$1.75M | – | 108 |
|
|
2023
Q3 | $1.75M | Buy |
185,613
+7,713
| +4% | +$72.8K | 0.32% | 80 |
|
|
2023
Q2 | $2.49M | Sell |
177,900
-276,052
| -61% | -$3.86M | 0.43% | 64 |
|
|
2023
Q1 | $8.52M | Buy |
453,952
+25,684
| +6% | +$482K | 1.85% | 21 |
|
|
2022
Q4 | $5.9M | Buy |
428,268
+23,450
| +6% | +$323K | 1.57% | 20 |
|
|
2022
Q3 | $7.74M | Sell |
404,818
-56,408
| -12% | -$1.08M | 2.2% | 14 |
|
|
2022
Q2 | $7.04M | Buy |
461,226
+53,768
| +13% | +$820K | 2.59% | 12 |
|
|
2022
Q1 | $8.3M | Buy |
407,458
+117,458
| +41% | +$2.39M | 2.43% | 15 |
|
|
2021
Q4 | $8.46M | Sell |
290,000
-160,000
| -36% | -$4.67M | 1.87% | 19 |
|
|
2021
Q3 | $9.71M | Sell |
450,000
-25,000
| -5% | -$539K | 2.46% | 14 |
|
|
2021
Q2 | $12.2M | Sell |
475,000
-200,000
| -30% | -$5.13M | 2.66% | 12 |
|
|
2021
Q1 | $12.3M | Sell |
675,000
-74,511
| -10% | -$1.36M | 2.86% | 10 |
|
|
2020
Q4 | $8.65M | Buy |
749,511
+265,264
| +55% | +$3.06M | 2.22% | 15 |
|
|
2020
Q3 | $3.69M | Buy |
484,247
+359,247
| +287% | +$2.74M | 0.98% | 41 |
|
|
2020
Q2 | $821K | Buy |
+125,000
| New | +$821K | 0.23% | 72 |
|
|
2020
Q1 | – | Sell |
-140,523
| Closed | -$1.08M | – | 79 |
|
|
2019
Q4 | $1.08M | Buy |
+140,523
| New | +$1.08M | 0.31% | 61 |
|